Trademark: 79312975
Word
ADAPTIMMUNE
Status Date
Tuesday, January 25, 2022
Registration Number
6624493
Registration Date
Tuesday, January 25, 2022
Filing Date
Wednesday, March 31, 2021
Published for Opposition
Tuesday, November 9, 2021
5 Pharmaceutical preparations for the treatment of cancer and autoimmune diseases; pharmaceutical immunotherapy preparations for use in cancer treatment; T-cell receptors , namely, pharmaceutical preparations for use in cancer treatment; pharmaceutical immunotherapy preparations comprising engineered T-cell receptors for use in cancer treatment; pharmaceutical immunotherapy preparations comprising genes encoding engineered T-cell receptors for use in cancer treatment
44 Medical treatment services; medical immunotherapy services; medical treatment services and medical treatment services for immune-therapy comprising harvesting a patient's white blood cells, combining white blood cells with an engineered T-cell receptor therapeutic, transducing the white blood cells with the gene encoding the engineered T-cell receptor and infusion of the transduced white blood cells back into the patient
The mark consists of a stylized circular design consisting of several curved parallel lines to the left of the stylized wording "ADAPTIMMUNE".
ADAPT IMMUNE
Aug 1, 2022
Final Decision Transaction Processed By Ib
Jul 8, 2022
Final Disposition Notice Sent To Ib
Jul 8, 2022
Final Disposition Processed
Apr 25, 2022
Final Disposition Notice Created, To Be Sent To Ib
Jan 25, 2022
Registered-Principal Register
Nov 9, 2021
Official Gazette Publication Confirmation E-Mailed
Nov 9, 2021
Published For Opposition
Oct 20, 2021
Notification Of Notice Of Publication E-Mailed
Oct 7, 2021
Approved For Pub - Principal Register
Sep 13, 2021
Teas/Email Correspondence Entered
Sep 13, 2021
Correspondence Received In Law Office
Sep 13, 2021
Teas Response To Office Action Received
Aug 15, 2021
Refusal Processed By Ib
Jul 27, 2021
Non-Final Action Mailed - Refusal Sent To Ib
Jul 27, 2021
Refusal Processed By Mpu
Jul 17, 2021
Non-Final Action (Ib Refusal) Prepared For Review
Jul 16, 2021
Non-Final Action Written
Jul 16, 2021
Assigned To Examiner
Jun 16, 2021
Application Filing Receipt Mailed
Jun 12, 2021
New Application Office Supplied Data Entered In Tram
Jun 10, 2021
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
